{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T18:06:48Z","timestamp":1759774008870},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T00:00:00Z","timestamp":1253145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10048-009-0217-x","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T07:28:48Z","timestamp":1253086128000},"page":"227-239","source":"Crossref","is-referenced-by-count":21,"title":["Intratumoral patterns of clonal evolution in gliomas"],"prefix":"10.1007","volume":"11","author":[{"given":"Ana Lu\u00edsa","family":"Vital","sequence":"first","affiliation":[]},{"given":"Maria Dolores","family":"Tabernero","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Crespo","sequence":"additional","affiliation":[]},{"given":"Olinda","family":"Rebelo","sequence":"additional","affiliation":[]},{"given":"Herm\u00ednio","family":"T\u00e3o","sequence":"additional","affiliation":[]},{"given":"Fernando","family":"Gomes","sequence":"additional","affiliation":[]},{"given":"Maria Celeste","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,9,17]]},"reference":[{"key":"217_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2007-131-397-G","volume":"131","author":"CR Miller","year":"2007","unstructured":"Miller CR, Perry A (2007) Glioblastoma. Arch Pathol Lab Med 131:397\u2013406","journal-title":"Arch Pathol Lab Med"},{"key":"217_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00401-005-0991-y","volume":"109","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93\u2013108","journal-title":"Acta Neuropathol"},{"key":"217_CR3","volume-title":"WHO classification of tumours of the central nervous system","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. IARC, Lyon"},{"key":"217_CR4","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1101\/gad.891601","volume":"15","author":"EA Maher","year":"2001","unstructured":"Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN et al (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311\u20131333","journal-title":"Genes Dev"},{"key":"217_CR5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11060-008-9533-5","volume":"88","author":"JE Wolff","year":"2008","unstructured":"Wolff JE, Berrak S, Koontz Webb SE, Zhang M (2008) Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24193 patients. J Neurooncol 88:57\u201363","journal-title":"J Neurooncol"},{"key":"217_CR6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"217_CR7","first-page":"6205","volume":"62","author":"EC Burton","year":"2002","unstructured":"Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J et al (2002) Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 62:6205\u20136210","journal-title":"Cancer Res"},{"key":"217_CR8","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/jnen\/62.11.1118","volume":"62","author":"CE Fuller","year":"2003","unstructured":"Fuller CE, Schmidt RE, Roth KA, Burger PC, Scheithauer BW et al (2003) Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial\/astrocytic features. J Neuropathol Exp Neurol 62:1118\u20131128","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","volume":"9","author":"HS Phillips","year":"2006","unstructured":"Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH et al (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9:157\u2013173","journal-title":"Cancer Cell"},{"key":"217_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-007-9358-7","volume":"84","author":"F Kramar","year":"2007","unstructured":"Kramar F, Zemanova Z, Michalova K, Babicka L, Ransdorfova S et al (2007) Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data. J Neurooncol 84:201\u2013211","journal-title":"J Neurooncol"},{"key":"217_CR11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/01.jnen.0000248549.14962.b2","volume":"65","author":"M Mizoguchi","year":"2006","unstructured":"Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN et al (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 65:1181\u20131188","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.jnen.0000235118.75182.94","volume":"65","author":"T Homma","year":"2006","unstructured":"Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL et al (2006) Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65:846\u2013854","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.21221","volume":"104","author":"A Korshunov","year":"2005","unstructured":"Korshunov A, Sycheva R, Golanov A (2005) The prognostic relevance of molecular alterations in glioblastomas for patients age<50\u00a0years. Cancer 104:825\u2013832","journal-title":"Cancer"},{"key":"217_CR14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1440-1789.2006.00735.x","volume":"27","author":"YK Jeon","year":"2007","unstructured":"Jeon YK, Park K, Park CK, Paek SH, Jung HW et al (2007) Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization. Neuropathology 27:10\u201320","journal-title":"Neuropathology"},{"key":"217_CR15","first-page":"4841","volume":"9","author":"C Walker","year":"2003","unstructured":"Walker C, du Plessis DG, Joyce KA, Machell Y, Thomson-Hehir J et al (2003) Phenotype versus genotype in gliomas displaying inter- or intratumoral histological heterogeneity. Clin Cancer Res 9:4841\u20134851","journal-title":"Clin Cancer Res"},{"key":"217_CR16","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1073\/pnas.0402870102","volume":"102","author":"Y Liang","year":"2005","unstructured":"Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD et al (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102:5814\u20139","journal-title":"Proc Natl Acad Sci U S A"},{"key":"217_CR17","first-page":"1602","volume":"63","author":"CL Nutt","year":"2003","unstructured":"Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG et al (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63:1602\u20131607","journal-title":"Cancer Res"},{"key":"217_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-4608(01)00650-1","volume":"135","author":"R Koschny","year":"2002","unstructured":"Koschny R, Koschny T, Froster UG, Krupp W, Zuber MA (2002) Comparative genomic hybridization in glioma: a meta-analysis of 509 cases. Cancer Genet Cytogenet 135:147\u2013159","journal-title":"Cancer Genet Cytogenet"},{"key":"217_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S1525-1578(10)60507-7","volume":"6","author":"RN Wiltshire","year":"2004","unstructured":"Wiltshire RN, Herndon JE 2nd, Lloyd A, Friedman HS, Bigner DD et al (2004) Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications. J Mol Diagn 6:166\u2013179","journal-title":"J Mol Diagn"},{"key":"217_CR20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jnen\/61.12.1078","volume":"61","author":"CE Fuller","year":"2002","unstructured":"Fuller CE, Wang H, Zhang W, Fuller GN, Perry A (2002) High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). J Neuropathol Exp Neurol 61:1078\u20131084","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergencyto.2003.09.012","volume":"151","author":"JK Cowell","year":"2004","unstructured":"Cowell JK, Matsui S, Wang YD, LaDuca J, Conroy J et al (2004) Application of bacterial artificial chromosome array-based comparative genomic hybridization and spectral karyotyping to the analysis of glioblastoma multiforme. Cancer Genet Cytogenet 151:36\u201351","journal-title":"Cancer Genet Cytogenet"},{"key":"217_CR22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.3171\/jns.2002.96.5.0815","volume":"96","author":"T Kamiryo","year":"2002","unstructured":"Kamiryo T, Tada K, Shiraishi S, Shinojima N, Nakamura H et al (2002) Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme. J Neurosurg 96:815\u2013822","journal-title":"J Neurosurg"},{"key":"217_CR23","first-page":"413","volume":"63","author":"Y Okada","year":"2003","unstructured":"Okada Y, Hurwitz EE, Esposito JM, Brower MA, Nutt CL et al (2003) Selection pressures of TP53 mutation and microenvironmental location influence epidermal growth factor receptor gene amplification in human glioblastomas. Cancer Res 63:413\u2013416","journal-title":"Cancer Res"},{"key":"217_CR24","first-page":"196","volume":"8","author":"K Ueki","year":"2002","unstructured":"Ueki K, Nishikawa R, Nakazato Y, Hirose T, Hirato J et al (2002) Correlation of histology and molecular genetic analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 astrocytic and oligodendroglial tumors. Clin Cancer Res 8:196\u2013201","journal-title":"Clin Cancer Res"},{"key":"217_CR25","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnen\/59.12.1087","volume":"59","author":"L Liu","year":"2000","unstructured":"Liu L, Ichimura K, Pettersson EH, Goike HM, Collins VP (2000) The complexity of the 7p12 amplicon in human astrocytic gliomas: detailed mapping of 246 tumors. J Neuropathol Exp Neurol 59:1087\u20131093","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR26","first-page":"4151","volume":"9","author":"LM Backlund","year":"2003","unstructured":"Backlund LM, Nilsson BR, Goike HM, Schmidt EE, Liu L et al (2003) Short postoperative survival for glioblastoma patients with a dysfunctional Rb1 pathway in combination with no wild-type PTEN. Clin Cancer Res 9:4151\u20134158","journal-title":"Clin Cancer Res"},{"key":"217_CR27","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1158\/0008-5472.CAN-04-1337","volume":"64","author":"H Ohgaki","year":"2004","unstructured":"Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T et al (2004) Genetic pathways to glioblastoma: a population-based study. Cancer Res 64:6892\u20136899","journal-title":"Cancer Res"},{"key":"217_CR28","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","volume":"170","author":"H Ohgaki","year":"2007","unstructured":"Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445\u20131453","journal-title":"Am J Pathol"},{"key":"217_CR29","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00005072-199607000-00007","volume":"55","author":"J Reifenberger","year":"1996","unstructured":"Reifenberger J, Ring GU, Gies U, Cobbers L, Oberstrass J et al (1996) Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 55:822\u2013831","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR30","first-page":"2897","volume":"62","author":"G Fulci","year":"2002","unstructured":"Fulci G, Ishii N, Maurici D, Gernert KM, Hainaut P et al (2002) Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion. Cancer Res 62:2897\u20132905","journal-title":"Cancer Res"},{"key":"217_CR31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S1525-1578(10)60527-2","volume":"6","author":"JM Sayagues","year":"2004","unstructured":"Sayagues JM, Tabernero MD, Maillo A, Espinosa A, Rasillo A et al (2004) Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical\/anaplastic lesions? J Mol Diagn 6:316\u2013325","journal-title":"J Mol Diagn"},{"key":"217_CR32","first-page":"4694","volume":"58","author":"K Harada","year":"1998","unstructured":"Harada K, Nishizaki T, Ozaki S, Kubota H, Ito H et al (1998) Intratumoral cytogenetic heterogeneity detected by comparative genomic hybridization and laser scanning cytometry in human gliomas. Cancer Res 58:4694\u20134700","journal-title":"Cancer Res"},{"key":"217_CR33","first-page":"353","volume":"28","author":"S Wemmert","year":"2006","unstructured":"Wemmert S, Romeike BF, Ketter R, Steudel WI, Zang KD et al (2006) Intratumoral genetic heterogeneity in pilocytic astrocytomas revealed by CGH-analysis of microdissected tumor cells and FISH on tumor tissue sections. Int J Oncol 28:353\u2013360","journal-title":"Int J Oncol"},{"key":"217_CR34","first-page":"209","volume":"24","author":"C Lopez-Gines","year":"2005","unstructured":"Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA et al (2005) Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. Clin Neuropathol 24:209\u2013218","journal-title":"Clin Neuropathol"},{"key":"217_CR35","first-page":"212","volume":"54","author":"E Necesalova","year":"2007","unstructured":"Necesalova E, Vranova V, Kuglik P, Cejpek P, Jarosova M et al (2007) Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology. Neoplasma 54:212\u2013218","journal-title":"Neoplasma"},{"key":"217_CR36","first-page":"6962","volume":"63","author":"N Shinojima","year":"2003","unstructured":"Shinojima N, Tada K, Shiraishi S, Kamiryo T, Kochi M et al (2003) Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res 63:6962\u20136970","journal-title":"Cancer Res"},{"key":"217_CR37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.5858\/2007-131-1585-SMSIHG","volume":"131","author":"RE McLendon","year":"2007","unstructured":"McLendon RE, Turner K, Perkinson K, Rich J (2007) Second messenger systems in human gliomas. Arch Pathol Lab Med 131:1585\u20131590","journal-title":"Arch Pathol Lab Med"},{"key":"217_CR38","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","volume":"12","author":"M Scaltriti","year":"2006","unstructured":"Scaltriti M, Baselga J (2006) The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12:5268\u20135272","journal-title":"Clin Cancer Res"},{"key":"217_CR39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jcb.21593","volume":"102","author":"L Li","year":"2007","unstructured":"Li L, Ross AH (2007) Why is PTEN an important tumor suppressor? J Cell Biochem 102:1368\u20131374","journal-title":"J Cell Biochem"},{"key":"217_CR40","first-page":"334","volume":"54","author":"A Hlobilkova","year":"2007","unstructured":"Hlobilkova A, Ehrmann J, Sedlakova E, Krejci V, Knizetova P et al (2007) Could changes in the regulation of the PI3K\/PKB\/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? Neoplasma 54:334\u2013341","journal-title":"Neoplasma"},{"key":"217_CR41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/j.seminoncol.2004.07.002","volume":"31","author":"RD Rao","year":"2004","unstructured":"Rao RD, James CD (2004) Altered molecular pathways in gliomas: an overview of clinically relevant issues. Semin Oncol 31:595\u2013604","journal-title":"Semin Oncol"},{"key":"217_CR42","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2152\/jmi.51.146","volume":"51","author":"N Ohtani","year":"2004","unstructured":"Ohtani N, Yamakoshi K, Takahashi A, Hara E (2004) The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest 51:146\u2013153","journal-title":"J Med Invest"},{"key":"217_CR43","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1158\/0008-5472.CAN-08-2097","volume":"68","author":"DT Jones","year":"2008","unstructured":"Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM et al (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68:8673\u20138677","journal-title":"Cancer Res"},{"key":"217_CR44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1097\/NEN.0b013e3181845622","volume":"67","author":"EE Bar","year":"2008","unstructured":"Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67:878\u2013887","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR45","first-page":"673","volume":"19","author":"V Jendrossek","year":"2001","unstructured":"Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lakomek M (2001) Induction of differentiation and tetraploidy by long-term treatment of C6 rat glioma cells with erucylphosphocholine. Int J Oncol 19:673\u2013680","journal-title":"Int J Oncol"},{"key":"217_CR46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.gde.2007.02.011","volume":"17","author":"NJ Ganem","year":"2007","unstructured":"Ganem NJ, Storchova Z, Pellman D (2007) Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev 17:157\u2013162","journal-title":"Curr Opin Genet Dev"},{"key":"217_CR47","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1038\/sj.emboj.7601886","volume":"26","author":"Y Liu","year":"2007","unstructured":"Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C et al (2007) Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1\/Cip1). EMBO J 26:4683\u20134693","journal-title":"EMBO J"},{"key":"217_CR48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ijc.21901","volume":"119","author":"B Tews","year":"2006","unstructured":"Tews B, Felsberg J, Hartmann C, Kunitz A, Hahn M et al (2006) Identification of novel oligodendroglioma-associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray-based expression profiling. Int J Cancer 119:792\u2013800","journal-title":"Int J Cancer"},{"key":"217_CR49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1158\/1078-0432.1119.11.3","volume":"11","author":"V Barbashina","year":"2005","unstructured":"Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M (2005) Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11:1119\u20131128","journal-title":"Clin Cancer Res"},{"key":"217_CR50","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1158\/1078-0432.CCR-07-0573","volume":"13","author":"M Weller","year":"2007","unstructured":"Weller M, Berger H, Hartmann C, Schramm J, Westphal M et al (2007) Combined 1p\/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Clin Cancer Res 13:6933\u20136937","journal-title":"Clin Cancer Res"},{"key":"217_CR51","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","volume":"66","author":"RB Jenkins","year":"2006","unstructured":"Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM et al (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852\u20139861","journal-title":"Cancer Res"},{"key":"217_CR52","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1750-3639.2004.tb00044.x","volume":"14","author":"J Felsberg","year":"2004","unstructured":"Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R et al (2004) Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p\/19q status with survival. Brain Pathol 14:121\u2013130","journal-title":"Brain Pathol"},{"key":"217_CR53","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00000421-200110000-00018","volume":"24","author":"RB Jenkins","year":"2001","unstructured":"Jenkins RB, Curran W, Scott CB, Cairncross G (2001) Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group. Am J Clin Oncol 24:506\u2013508","journal-title":"Am J Clin Oncol"},{"key":"217_CR54","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","volume":"64","author":"H Ohgaki","year":"2005","unstructured":"Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479\u2013489","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00401-006-0142-0","volume":"113","author":"M Qu","year":"2007","unstructured":"Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H et al (2007) Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas. Acta Neuropathol 113:129\u2013136","journal-title":"Acta Neuropathol"},{"key":"217_CR56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cancergencyto.2008.03.009","volume":"184","author":"KS Reddy","year":"2008","unstructured":"Reddy KS (2008) Assessment of 1p\/19q deletions by fluorescence in situ hybridization in gliomas. Cancer Genet Cytogenet 184:77\u201386","journal-title":"Cancer Genet Cytogenet"},{"key":"217_CR57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.jnen.0000240465.33628.87","volume":"65","author":"DT Jones","year":"2006","unstructured":"Jones DT, Ichimura K, Liu L, Pearson DM, Plant K et al (2006) Genomic analysis of pilocytic astrocytomas at 0.97\u00a0Mb resolution shows an increasing tendency toward chromosomal copy number change with age. J Neuropathol Exp Neurol 65:1049\u20131058","journal-title":"J Neuropathol Exp Neurol"},{"key":"217_CR58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cancergencyto.2007.08.019","volume":"180","author":"V Lima-Ramos","year":"2008","unstructured":"Lima-Ramos V, Pacheco-Figueiredo L, Costa S, Pardal F, Silva A et al (2008) TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genet Cytogenet 180:14\u201319","journal-title":"Cancer Genet Cytogenet"},{"key":"217_CR59","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbrc.2006.09.148","volume":"351","author":"Y Chang","year":"2006","unstructured":"Chang Y, Berenson JR, Wang Z, Deuel TF (2006) Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells. Biochem Biophys Res Commun 351:336\u2013339","journal-title":"Biochem Biophys Res Commun"}],"container-title":["neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-009-0217-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10048-009-0217-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-009-0217-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T14:57:44Z","timestamp":1710601064000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10048-009-0217-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,17]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["217"],"URL":"https:\/\/doi.org\/10.1007\/s10048-009-0217-x","relation":{},"ISSN":["1364-6745","1364-6753"],"issn-type":[{"value":"1364-6745","type":"print"},{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,17]]}}}